Cite
HARVARD Citation
White, H. et al. (n.d.). Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study. Journal of the American Heart Association. 2 (5), p. n/a. [Online].